FATE THERAPEUTICS INC Earnings Per Share, Basic and Diluted
FATE THERAPEUTICS INC (FATE) reported Earnings Per Share, Basic and Diluted of -$0.68 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-04
- FATE THERAPEUTICS INC earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.68.
- FATE THERAPEUTICS INC earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.72.
- FATE THERAPEUTICS INC earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.45.
- FATE THERAPEUTICS INC earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.58.
- FATE THERAPEUTICS INC earnings per share, basic and diluted for fiscal 2021 was -$2.24.
- FATE THERAPEUTICS INC earnings per share, basic and diluted for fiscal 2020 was -$2.10.
- FATE THERAPEUTICS INC earnings per share, basic and diluted for fiscal 2019 was -$1.44.
- FATE THERAPEUTICS INC earnings per share, basic and diluted for fiscal 2018 was -$1.19.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.68 10-Q · filed 2022-05-04 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.85 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.44 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2021-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.17 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.76 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.24 10-K · filed 2022-02-28 |
| 2021-09-30 | -$0.45 10-Q · filed 2021-11-04 | -$1.04 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.52 10-Q · filed 2021-11-04 | -$2.12 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2021-06-30 | -$0.58 10-Q · filed 2021-08-04 | -$1.07 10-Q · filed 2021-08-04 | -$1.67 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.34 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2021-03-31 | -$0.48 10-Q · filed 2022-05-04 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.76 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.13 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2020-12-31 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.28 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.65 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.10 10-K · filed 2022-02-28 |
| 2020-09-30 | -$0.68 10-Q · filed 2021-11-04 | -$1.04 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$1.49 10-Q · filed 2021-11-04 | -$1.87 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2020-06-30 | -$0.35 10-Q · filed 2021-08-04 | -$0.79 10-Q · filed 2021-08-04 | -$1.17 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.56 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2020-03-31 | -$0.44 10-Q · filed 2021-05-05 | -$0.82 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.21 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.58 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2019-12-31 | -$0.37 10-K · filed 2020-03-02 | -$0.77 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.13 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.44 10-K · filed 2022-02-28 |
| 2019-09-30 | -$0.40 10-Q · filed 2020-11-05 | -$0.76 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$1.06 10-Q · filed 2020-11-05 | -$1.31 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2019-06-30 | -$0.36 10-Q · filed 2020-08-05 | -$0.66 10-Q · filed 2020-08-05 | -$0.91 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.22 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2019-03-31 | -$0.30 10-Q · filed 2020-05-11 | -$0.55 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$0.86 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.22 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2018-12-31 | -$0.25 10-K · filed 2020-03-02 | -$0.55 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$0.92 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.19 10-K · filed 2021-02-24 |
| 2018-09-30 | -$0.31 10-K · filed 2020-03-02 | -$0.68 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$0.95 10-Q · filed 2019-11-05 | -$1.24 derived: net income ÷ weighted average shares · filed 2020-03-02 |
| 2018-06-30 | -$0.37 10-K · filed 2020-03-02 | -$0.64 10-Q · filed 2019-08-06 | -$0.93 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$1.19 derived: net income ÷ weighted average shares · filed 2020-03-02 |
| 2018-03-31 | -$0.27 10-K · filed 2020-03-02 | -$0.55 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$0.81 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$1.05 derived: net income ÷ weighted average shares · filed 2020-03-02 |
| 2017-12-31 | -$0.29 10-K · filed 2019-03-05 | -$0.54 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$0.78 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$1.02 10-K · filed 2020-03-02 |
| 2017-09-30 | -$0.26 10-K · filed 2019-03-05 | -$0.49 derived: net income ÷ weighted average shares · filed 2019-03-05 | -$0.74 10-Q · filed 2018-11-01 | -$0.95 derived: net income ÷ weighted average shares · filed 2019-03-05 |
| 2017-06-30 | -$0.23 10-K · filed 2019-03-05 | -$0.48 10-Q · filed 2018-08-06 | -$0.69 derived: net income ÷ weighted average shares · filed 2019-03-05 | -$0.96 derived: net income ÷ weighted average shares · filed 2019-03-05 |
| 2017-03-31 | -$0.24 10-K · filed 2019-03-05 | -$0.46 derived: net income ÷ weighted average shares · filed 2019-03-05 | -$0.73 derived: net income ÷ weighted average shares · filed 2019-03-05 | -$1.01 derived: net income ÷ weighted average shares · filed 2019-03-05 |
| 2016-12-31 | -$0.21 10-K · filed 2018-03-05 | -$0.48 derived: net income ÷ weighted average shares · filed 2019-03-05 | -$0.77 derived: net income ÷ weighted average shares · filed 2019-03-05 | -$1.05 10-K · filed 2019-03-05 |
| 2016-09-30 | -$0.27 10-K · filed 2018-03-05 | -$0.56 derived: net income ÷ weighted average shares · filed 2018-03-05 | -$0.85 10-Q · filed 2017-11-01 | -$1.11 derived: net income ÷ weighted average shares · filed 2018-03-05 |
| 2016-06-30 | -$0.29 10-K · filed 2018-03-05 | -$0.58 10-Q · filed 2017-08-14 | -$0.84 derived: net income ÷ weighted average shares · filed 2018-03-05 | -$1.08 derived: net income ÷ weighted average shares · filed 2018-03-05 |
| 2016-03-31 | -$0.29 10-K · filed 2018-03-05 | -$0.55 derived: net income ÷ weighted average shares · filed 2018-03-05 | -$0.79 derived: net income ÷ weighted average shares · filed 2018-03-05 | -$1.11 derived: net income ÷ weighted average shares · filed 2018-03-05 |
| 2015-12-31 | -$0.26 10-K · filed 2017-03-16 | -$0.50 derived: net income ÷ weighted average shares · filed 2018-03-05 | -$0.82 derived: net income ÷ weighted average shares · filed 2018-03-05 | -$1.18 10-K · filed 2018-03-05 |
| 2015-09-30 | -$0.24 10-K · filed 2017-03-16 | -$0.56 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.92 10-Q · filed 2016-11-07 | -$1.23 derived: net income ÷ weighted average shares · filed 2017-03-16 |
| 2015-06-30 | -$0.33 10-K · filed 2017-03-16 | -$0.70 10-Q · filed 2016-08-08 | -$1.01 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$1.33 derived: net income ÷ weighted average shares · filed 2017-03-16 |
| 2015-03-31 | -$0.38 10-K · filed 2017-03-16 | -$0.69 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$1.01 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$1.31 derived: net income ÷ weighted average shares · filed 2017-03-16 |
| 2014-12-31 | -$0.30 10-K · filed 2016-03-03 | -$0.63 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.92 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$1.27 10-K · filed 2017-03-16 |
| 2014-09-30 | -$0.32 10-K · filed 2016-03-03 | -$0.62 derived: net income ÷ weighted average shares · filed 2016-03-03 | -$0.96 10-Q · filed 2015-11-03 | -$1.25 derived: net income ÷ weighted average shares · filed 2016-03-03 |
| 2014-06-30 | -$0.30 10-K · filed 2016-03-03 | -$0.64 10-Q · filed 2015-08-05 | -$0.93 derived: net income ÷ weighted average shares · filed 2016-03-03 | -$1.61 derived: net income ÷ weighted average shares · filed 2016-03-03 |
| 2014-03-31 | -$0.34 10-K · filed 2016-03-03 | -$0.63 derived: net income ÷ weighted average shares · filed 2016-03-03 | -$1.36 derived: net income ÷ weighted average shares · filed 2016-03-03 | -$2.28 derived: net income ÷ weighted average shares · filed 2016-03-03 |
| 2013-12-31 | -$0.29 10-K · filed 2015-03-12 | -$1.12 derived: net income ÷ weighted average shares · filed 2016-03-03 | -$2.33 derived: net income ÷ weighted average shares · filed 2016-03-03 | -$3.54 10-K · filed 2016-03-03 |
| 2013-09-30 | -$4.81 10-K · filed 2015-03-12 | -$9.28 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$12.24 10-Q · filed 2014-11-12 | -$15.77 derived: net income ÷ weighted average shares · filed 2015-03-12 |
| 2013-06-30 | -$4.46 10-K · filed 2015-03-12 | -$7.41 10-Q · filed 2014-08-12 | -$10.92 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$14.44 derived: net income ÷ weighted average shares · filed 2015-03-12 |
| 2013-03-31 | -$2.92 10-K · filed 2015-03-12 | -$6.43 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$9.93 derived: net income ÷ weighted average shares · filed 2015-03-12 | |
| 2012-12-31 | -$3.51 10-K · filed 2014-03-17 | -$7.02 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$13.06 10-K · filed 2015-03-12 | |
| 2012-09-30 | -$3.51 10-K · filed 2014-03-17 | -$9.52 10-Q · filed 2013-11-13 | ||
| 2012-06-30 | -$2.58 10-K · filed 2014-03-17 | |||
| 2012-03-31 | -$3.43 10-K · filed 2014-03-17 | |||
| 2011-12-31 | -$16.16 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |